168 related articles for article (PubMed ID: 35977459)
21. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with perceived ease of access to syringes in Appalachian North Carolina.
Carpenter DM; Zule WA; Hennessy CM; Evon DM; Hurt CB; Ostrach B
J Rural Health; 2023 Jan; 39(1):212-222. PubMed ID: 35819251
[TBL] [Abstract][Full Text] [Related]
23. Weathering the Storm: Syringe Services Program Laws and Human Immunodeficiency Virus During the COVID-19 Pandemic.
Jackson H; Dunphy C; Grist MB; Jiang X; Xu L; Guy GP; Salvant-Valentine S
J Acquir Immune Defic Syndr; 2023 Dec; 94(5):395-402. PubMed ID: 37949442
[TBL] [Abstract][Full Text] [Related]
24. Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews.
Carry M; Bixler D; Weng MK; Doshani M; Roberts E; Montgomery MP
Harm Reduct J; 2022 Sep; 19(1):100. PubMed ID: 36050735
[TBL] [Abstract][Full Text] [Related]
25. Capacity for sustainment of recently established syringe service programs in Appalachian Kentucky: The central role of staff champions.
Cooper HLF; Gross S; Klein E; Fadanelli M; Ballard A; Lockard S; Batty E; Young A; Ibragimov U
Drug Alcohol Rev; 2022 May; 41(4):863-872. PubMed ID: 35112747
[TBL] [Abstract][Full Text] [Related]
26. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
27. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
[TBL] [Abstract][Full Text] [Related]
28. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
[TBL] [Abstract][Full Text] [Related]
29. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
[TBL] [Abstract][Full Text] [Related]
30. Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration.
Allen ST; Danforth S; Grieb SM; Glick JL; Harris SJ; Tomko C; Sherman SG
Harm Reduct J; 2022 Sep; 19(1):109. PubMed ID: 36180853
[TBL] [Abstract][Full Text] [Related]
31. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
[TBL] [Abstract][Full Text] [Related]
32. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.
Jakubowski A; Rath C; Harocopos A; Wright M; Welch A; Kattan J; Navos Behrends C; Lopez-Castro T; Fox AD
Harm Reduct J; 2022 Jul; 19(1):75. PubMed ID: 35818071
[TBL] [Abstract][Full Text] [Related]
33. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
34. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.
Bartholomew TS; Feaster DJ; Patel H; Forrest DW; Tookes HE
J Subst Abuse Treat; 2021 Aug; 127():108344. PubMed ID: 34134863
[TBL] [Abstract][Full Text] [Related]
35. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.
Kesten JM; Holland A; Linton MJ; Family H; Scott J; Horwood J; Hickman M; Telfer M; Ayres R; Hussey D; Wilkinson J; Hines LA
Int J Drug Policy; 2021 Dec; 98():103391. PubMed ID: 34343945
[TBL] [Abstract][Full Text] [Related]
36. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.
López-Castro T; Sohler N; Riback L; Bravo G; Ohlendorf E; Ghiroli M; Fox AD
Harm Reduct J; 2024 Jun; 21(1):108. PubMed ID: 38824597
[TBL] [Abstract][Full Text] [Related]
37. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
[TBL] [Abstract][Full Text] [Related]
38. Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021.
Des Jarlais DC; Behrends CN; Corcorran MA; Glick SN; Perlman DC; Kapadia SN; Lu X; Feelemyer J; LaKosky P; Prohaska SM; Schackman BR
Public Health Rep; 2022; 137(6):1066-1069. PubMed ID: 36113105
[TBL] [Abstract][Full Text] [Related]
39. Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City.
Muncan B; Jordan AE; Perlman DC; Frank D; Ompad DC; Walters SM
Subst Use Misuse; 2021; 56(5):728-737. PubMed ID: 33682610
[No Abstract] [Full Text] [Related]
40. A wound care and immunization needs assessment for participants of a mobile syringe services program in Austin, TX.
Britton TR; Clague MR; Zagorski CM; Hill LG; Loera LJ
J Am Pharm Assoc (2003); 2023; 63(1):361-365.e1. PubMed ID: 36549930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
